Publications | Lund University Publications

1 – 9 of 9

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Miller%2C+Kurt%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Miller%2C+Kurt%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2021
Mark Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11
Reza, Mariana ^LU ; Wirth, Manfred ; Tammela, Teuvo ; Cicalese, Virgilio ; Veiga, Francisco Gomez ; Mulders, Peter ; Miller, Kurt ; Tubaro, Andrea ; Debruyne, Frans and Patel, Anup , et al. (2021) In European Urology Oncology 4(1). p.49-55
- Contribution to journal › Article
2017
Mark Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer : Extended Analysis of the Phase 3 PREVAIL Study
Beer, Tomasz M. ; Armstrong, Andrew J ; Rathkopf, Dana E ; Loriot, Yohann ; Sternberg, Cora N. ; Higano, Celestia S. ; Iversen, Peter ; Evans, Christopher P. ; Kim, Choung Soo and Kimura, Go , et al. (2017) In European Urology 71(2). p.151-154
- Contribution to journal › Article
2015
Mark Achievements and Perspectives in Prostate Cancer Phase 3 Trials from Genitourinary Research Groups in Europe: Introducing the Prostate Cancer Consortium in Europe.
Fizazi, Karim ; Abrahamsson, Per-Anders ^LU ; Ahlgren, Göran ^LU ; Bellmunt, Joaquim ; Castellano, Daniel ; Culine, Stephane ; de Wit, Ronald ; Gillessen, Silke ; Gschwend, Juergen E and Hamdy, Freddie , et al. (2015) In European Urology 67(5). p.904-912
- Contribution to journal › Scientific review
Mark Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302) : final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
Ryan, Charles J ; Smith, Matthew R ; Fizazi, Karim ; Saad, Fred ; Mulders, Peter F A ; Sternberg, Cora N ; Miller, Kurt ; Logothetis, Christopher J ; Shore, Neal D and Small, Eric J , et al. (2015) In The Lancet Oncology 16(2). p.60-152
- Contribution to journal › Article
2014
Mark Enzalutamide in metastatic prostate cancer before chemotherapy
Beer, Tomasz M ; Armstrong, Andrew J ; Rathkopf, Dana E ; Loriot, Yohann ; Sternberg, Cora N ; Higano, Celestia S ; Iversen, Peter ; Bhattacharya, Suman ; Carles, Joan and Chowdhury, Simon , et al. (2014) In New England Journal of Medicine 371(5). p.33-424
- Contribution to journal › Article
2009
Mark Treatment of prostate cancer with hormonal therapy in Europe
Miller, Kurt ; Anderson, John and Abrahamsson, Per-Anders ^LU (2009) In BJU International 103. p.41311-41311
- Contribution to journal › Article
Mark Preserving bone health in patients with hormone-sensitive prostate cancer: the role of bisphosphonates
Saad, Fred ; Abrahamsson, Per-Anders ^LU and Miller, Kurt (2009) In BJU International 104(11). p.1573-1579
- Contribution to journal › Scientific review
2008
Mark Management of advanced prostate cancer: can we improve on androgen deprivation therapy?
Anderson, J ; Abrahamsson, Per-Anders ^LU ; Crawford, David ; Miller, Kurt and Tombal, Bertrand (2008) In BJU International 101. p.1497-1501
- Contribution to journal › Article
2007
Mark The continuing role of PSA in the detection and management of prostate cancer
Miller, Kurt ; Abrahamsson, Per-Anders ^LU ; Akakura, Koichiro ; Debruyne, Frans M. J. ; Evans, Christopher P. and Klotz, Laurence (2007) In European Urology. Supplement 6(3). p.327-333
- Contribution to journal › Article

your query:: Remove author: Miller, Kurt